BJDX vs CL · $5.0M cap vs P/E 34, rev $10.69B
Bluejay Diagnostics Inc (BJDX) versus Colgate-Palmolive Company (CL) — a side-by-side from cached financials, not a winner call.
Bluejay Diagnostics Inc (BJDX) is a medical devices company listed on US.
Colgate-Palmolive Company (CL) is a household & personal products company listed on US.
BJDX does not have a complete income-statement cache yet.
Latest reported CL revenue for 2026-06-30 was $10.69B. Net income was $1.34B. CL currently screens at market cap $70.88B and trailing P/E 34.3.
BJDX currently screens at market cap $5.0M. CL currently screens at market cap $70.88B and trailing P/E 34.3.
Not investment advice. Open the BJDX and CL stock pages for the full models.
Not investment advice.